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Objectives
Subtype specific differences in the development of drug
resistance mutations have been reported for reverse tran-
scriptase and protease. Therefore, it is also important to
compare the enzymatic activities of purified HIV-1 inte-
grase (IN) from subtypes B and C in the wildtype (wt)
enzymes, as well as those containing drug resistance
mutations. We now report on the enzymatic activities of
both wt IN enzymes and those containing either the E92Q
or N155H mutations or both mutations together.
Methods
To evaluate the enzymatic activities from non-B subtypes
we cloned subtype C IN from pINDIE-C1 into a prokary-
otic protein expression vector, inserted solubility muta-
tions, described previously for subtype B IN, and
resistance mutations utilizing site-directed mutagenesis.
We then expressed and purified the relevant proteins. The
catalytic activities of both wt enzymes were analyzed
through biochemical assays for 3' processing and strand
transfer (3' P and ST respectively). An extensive biochem-
ical characterization of all purified integrase enzymes was
performed, both in the presence and absence of IN inhib-
itors (Raltegravir, Elvitegravir and MK-2048).
Results
Our results indicate that the enzymatic activities of wt sub-
type B and C integrases are not significantly different, sug-
gesting that there is little variation between subtypes B
and C in regard to integrase function. In addition, wt
enzymes of both subtypes displayed similar sensitivity to
the IN inhibitors. The double mutant E92Q/N155H
enzymes showed higher resistance to IN inhibitors than
did enzymes containing only single mutations, and differ-
ences between mutated enzymes of subtype B versus C
origin in regard to levels of resistance were demonstrable
but not pronounced. This is the first report on the enzy-
matic activity of both wt and drug resistant subtype C IN
enzymes.
Conclusion
IN from subtypes B and C behave similarly in biochemical
assays and in regard to susceptibility to IN inhibitors.
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